Related Experiment Video
Updated: Feb 14, 2026
05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
1.1K
Proteomic biomarkers for lung cancer progression
Yanjiao Ren1, Shishun Zhao2, Dandan Jiang2
1College of Computer Science & Technology, & Key Laboratory of Symbolic Computation & Knowledge Engineering of Ministry of Education, Jilin University, Changchun, Jilin 130012, PR China.
Biomarkers in Medicine
|February 10, 2018
Summary
This study developed accurate proteomic models to classify lung adenocarcinoma and lung squamous-cell carcinoma progression stages. Early diagnosis through these biomarkers can improve patient outcomes.
Area of Science:
- Oncology
- Proteomics
- Genomics
Background:
- Lung adenocarcinoma (LUAD) and lung squamous-cell carcinoma (LUSC) are leading causes of cancer mortality, accounting for 70% of lung cancer cases.
- Early diagnosis and treatment are crucial for improving patient survival and quality of life.
Purpose of the Study:
- To screen proteomic datasets for LUAD and LUSC.
- To develop classification models for predicting the progression stages of LUAD and LUSC.
- To analyze transcriptomic datasets for biomarker validation.
Main Methods:
- Comprehensive screening of proteomic datasets for LUAD and LUSC.
- Development of classification models utilizing proteomic data.
- Comparative analysis with transcriptomic datasets.
Main Results:
- Classification models achieved high accuracies: 86.51% for LUAD and 89.47% for LUSC.
- Proposed biomarkers demonstrated significant power in predicting cancer stage.
- Transcriptomic analysis supported the utility of proteomic biomarkers.
Conclusions:
- Proteomic analysis offers a promising approach for accurate staging of LUAD and LUSC.
- The developed models and biomarkers can aid in early diagnosis and treatment planning.
- Advancements in proteomic technologies will further enhance predictive capabilities.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:33Proteomics
9.9K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
9.9K
01:47Lung Capacity
56.5K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.5K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
934
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
934
01:13Pleura of the Lungs
7.8K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.8K